Overview

HealthPrize is an app-based consumer health engagement platform that motivates people with chronic conditions to take control of their care plan. The program supports habit change by rewarding patients for engaging in healthy activities. Patients are rewarded for all engagement with the platform, including self-reporting their medication taking and engaging with condition and brand-specific educational information.

How it works

Patients interact with the HealthPrize platform for roughly 2 minutes a day by engaging with educational content and program activities targeted to their reported medications. Gamification and behavioral economics principles encourage patients to interact with the platform consistently. In addition, patients earn points for their engagement, which are redeemable for rewards.

Scoring

HealthPrize has been scored below according to it’s ability to serve the TB market for low- and middle-income countries (LMICs) along Fit for Purpose and Technical Specifications metrics. Note that higher scores equate to a greater ability to serve the market. For example, if a product scores well in the Provider Burden subcategory, that means that the burden for the provider is low.

For full descriptions of the sub-categories, see the 2021 DAT Market Landscape.

Fit for Purpose

Provider Burden100%
100%
Patient Burden50%
50%
Reach0%
0%
Barriers to Entry100%
100%
Accuracy0%
0%
Evidence0%
0%

Technical Specifications

Range100%
100%
Electricity0%
0%
Dosing History50%
50%
Data Integration0%
0%
Portability100%
100%
Reminders0%
0%

Advantages

  • Novel approach to adherence based on gamification and incentives
  • No device to set up or maintain
  • Easy to use if you have a smartphone
  • Encourages patients to learn about their condition, deepening their understanding about the importance of adherence

Disadvantages

  • Requires a smartphone
  • Does not track adherence or transmit data to providers
  • Has not been used for TB or in LMICs

Access

For more information, please visit the HealthPrize website.